Download PDF
Fortschr Neurol Psychiatr 2008; 76(5): 263-271
DOI: 10.1055/s-2008-1038154
Originalarbeit
© Georg Thieme Verlag Stuttgart · New York

Komorbidität von Sucht und anderen psychischen Störungen - Grundlagen und evidenzbasierte Therapie

Comorbidity of Substance Use and other Psychiatric Disorders - Theoretical Foundation and Evidence Based TherapyE.  Gouzoulis-Mayfrank1
  • 1Klinik für Psychiatrie und Psychotherapie, Universitätsklinik Köln (Direktor: Prof. Dr. J. Klosterkötter)
Further Information

Publication History

Publication Date:
26 March 2008 (online)

    Permissions and Reprints

Corrected by:

Komorbidität, Sucht und andere psychische Störungen - Grundlagen und evidenzbasierte TherapieFortschr Neurol Psychiatr 2008; 76(05): E1-E1
DOI: 10.1055/s-2008-1038169

Zusammenfassung

Das Vorkommen von 2 oder mehr psychischen Erkrankungen bei einem Individuum (Komorbidität, Doppeldiagnose) ist keine seltene Ausnahme, sondern ein häufiges und klinisch-therapeutisch relevantes Phänomen, zumal komorbide Patienten überzufällig häufig schwere Krankheitsausprägungen aufweisen und eine intensive therapeutische Betreuung benötigen, die den Besonderheiten beider bzw. aller psychischen Störungen und ihrer wechselseitigen Beziehungen Rechnung tragen muss. In der vorliegenden Übersicht werden die Grundlagen der Komorbidität von Sucht mit anderen psychischen Störungen behandelt. Es werden die Prävalenzdaten und die Erklärungsmodelle vorgestellt, die klinischen Charakteristika und Besonderheiten des Verlaufs komorbider Patienten beschrieben und allgemeine Therapieprinzipien, u. a. die Vorteile integrierter Behandlungsprogramme, erläutert. Hinsichtlich spezifischer pharmako- und psychotherapeutischer Maßnahmen für die häufigsten Komorbiditäten wurde eine systematische Literaturrecherche in den Datenbanken MEDLINE, EMBASE und PsycInfo (bis 12/2007) durchgeführt und die identifizierten Studien wurden hinsichtlich der Qualität ihres Designs beurteilt. Auf dieser Grundlage wird die Wirksamkeit therapeutischer Programme evidenzbasiert dargestellt und Therapieempfehlungen gestuft nach dem Grad ihrer Fundierung ausgesprochen. In der Zusammenschau sind integrierte Behandlungsprogramme in der Regel erfolgreich, solange die mehrdimensionalen Defizite der komorbiden Patienten berücksichtigt, die verschiedenen Therapiebausteine aufeinander angepasst und adaptiert, und die Behandlungsziele realistisch gesetzt sind. Für die Zukunft wäre eine stärkere Verbreitung der integrierten Behandlung mit Implementierung entsprechender Programme in die Regelversorgung wünschenswert.

Abstract

The coincidence of two or more psychiatric disorders in the same person (comorbidity or dual diagnosis) is no rare exception. It is rather common and therapeutically highly relevant. Comorbid patients exhibit frequently severe manifestations of the disorder(s) and they require intensive treatment to meet their special needs and the interdependencies of their disorders. The present overview deals with the theoretical foundations of comorbidity of substance use and other psychiatric disorders. We present data on the prevalence of different comorbidities and discuss the models, which have been proposed to explain how substance use and other disorders relate with each other. Furthermore, we describe the clinical characteristics and long-term course of comorbid patients, as well as some general therapeutic principles including the advantages of integrated therapeutic programmes. In addition, we carried out a systematic literature search on specific pharmaco- and psychotherapies for common comorbidities using the databases MEDLINE, EMBASE and PsycInfo (up to December 2007), and assessed the methodological quality of the identified trials. Based on this search we present the empirical evidence for the effectiveness of specific treatments and make therapeutic recommendations which are graded according to the strength of existing evidence. In conclusion, integrated treatment programs are more effective, provided they take into account the multiple deficits of comorbid patients, adjust and adapt the different therapeutic components to each other, and set realistic goals. The next step should be a broader application of integrated treatment programs and their adoption as standard treatment within the national health systems.

Schlüsselwörter

Komorbidität - Sucht - Doppeldiagnose - Pharmakotherapie - Psychotherapie

Key words

comorbidity - substance use disorders - dual diagnosis - pharmacotherapy - psychotherapy

Literatur

  • 1 Kessler R C, McGonagle K A, Zhao S, Nelson C B, Hughes M, Eshleman S, Wittchen H U, Kendler K S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.  Arch Gen Psychiatry. 1994;  51 8-19
    Google Scholar
  • 2 Kessler R C, Chiu W T, Demler O, Merikangas K R, Walters E E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.  Arch Gen Psychiatry. 2005;  62 617-627
    Google Scholar
  • 3 Regier D A, Farmer M E, Rae D S, Locke B Z, Keith S J, Judd L L, Goodwin F K. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.  JAMA. 1990;  264 2511-2518
    Google Scholar
  • 4 Moran P, Coffey C, Mann A, Carlin J B, Patton G C. Personality and substance use disorders in young adults.  Br J Psychiatry. 2006;  188 374-379
    Google Scholar
  • 5 Jacobsen L K, Southwick S M, Kosten T R. Substance use disorders in patients with posttraumatic stress disorder: a review of the literature.  Am J Psychiatry. 2001;  158 1184-1190
    Google Scholar
  • 6 Kalbag A S, Levin F R. Adult ADHD and substance abuse: diagnostic and treatment issues.  Subst Use Misuse. 2005;  40 1955-1958
    Google Scholar
  • 7 Mueser K T, Drake R E, Wallach M A. Dual diagnosis: a review of etiological theories.  Addict Behav. 1998;  23 717-734
    Google Scholar
  • 8 Moggi F. Etiological theories on the relationship of mental disorders and substance use disorders. In: Stohler R, Rössler W (Hrsg). Dual diagnosis: The evolving conceptual framework: Basel: Karger 2005: 1-14
    Google Scholar
  • 9 Iacono W G, Carlson S R, Taylor J, Elkins I J, McGue M. Behavioral disinhibition and the development of substance-use disorders: findings from the Minnesota Twin Family Study.  Dev Psychopathol. 1999;  11 869-900
    Google Scholar
  • 10 Gouzoulis-Mayfrank E. Komorbidität Psychose und Sucht - Grundlagen und Praxis. Mit Manualen für die Psychoedukation und Verhaltenstherapie. Darmstadt: Steinkopff 2007
    Google Scholar
  • 11 Levin F R, Hennessy G. Bipolar disorder and substance abuse.  Biol Psychiatry. 2004;  56 738-748
    Google Scholar
  • 12 Drake R E, Mueser K T, Brunette M F, McHugo G J. A review of treatments for people with severe mental illnesses and co-occurring substance use disorders.  Psychiatr Rehabil J. 2004;  27 360-374
    Google Scholar
  • 13 Brunette M F, Mueser K T, Drake R E. A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders.  Drug Alcohol Rev. 2004;  23 471-481
    Google Scholar
  • 14 Brunette M F, Mueser K T. Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder.  J Clin Psychiatry. 2006;  67 Suppl 7 10-17
    Google Scholar
  • 15 Green A I, Drake R E, Brunette M F, Noordsy D L. Schizophrenia and co-occurring substance use disorder.  Am J Psychiatry. 2007;  164 402-408
    Google Scholar
  • 16 Mangrum L F, Spence R T, Lopez M. Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders.  J Subst Abuse Treat. 2006;  30 79-84
    Google Scholar
  • 17 Mulrow C D, Oxman A D. Cochrane Collaboration Handbook. In: The Cochrane Collaboration. The Cochrane Library: Oxford: Update Software 2004
    Google Scholar
  • 18 Carroll K M. Behavioral therapies for co-occurring substance use and mood disorders.  Biol Psychiatry. 2004;  56 778-784
    Google Scholar
  • 19 Stohler R, Rössler W. Dual Diagnosis. The evolving conceptual framework. Basel: Karger 2005
    Google Scholar
  • 20 American Psychiatric Association (APA) .Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. Washington, DC: American Psychiatric Association 1995: 1-59
    Google Scholar
  • 21 Petrakis I L, Nich C, Ralevski E. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.  Schizophr Bull. 2006;  32 644-654
    Google Scholar
  • 22 Stuyt E B, Sajbel T A, Allen M H. Differing Effects of Antipsychotic Medications on Substance Abuse Treatment Patients with Co-occurring Psychotic and Substance Abuse Disorders.  Am J Addict. 2006;  15 166-173
    Google Scholar
  • 23 Brunette M F, Drake R E, Xie H, McHugo G J, Green A I. Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders.  Schizophr Bull. 2006;  32 637-643
    Google Scholar
  • 24 Rubio G, Martinez I, Ponce G, Jimenez-Arriero M A, Lopez-Munoz F, Alamo C. Long-acting injectable risperidone compared with zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity.  Can J Psychiatry. 2006;  51 531-539
    Google Scholar
  • 25 Sayers S L, Campbell E C, Kondrich J, Mann S C, Cornish J, O'Brien C, Caroff S N. Cocaine abuse in schizophrenic patients treated with olanzapine versus haloperidol.  J Nerv Ment Dis. 2005;  193 379-386
    Google Scholar
  • 26 Cornelius J R, Clark D B, Bukstein O G, Salloum I M. Treatment of co-occurring alcohol, drug, and psychiatric disorders.  Recent Dev Alcohol. 2005;  17 349-365
    Google Scholar
  • 27 Brady K T, Verduin M L. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.  Subst Use Misuse. 2005;  40 2021-2041
    Google Scholar
  • 28 Brown E S. Management of comorbid bipolar disorder and substance abuse.  J Clin Psychiatry. 2006;  67 e05
    Google Scholar
  • 29 Salloum I M, Cornelius J R, Daley D C, Kirisci L, Himmelhoch J M, Thase M E. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.  Arch Gen Psychiatry. 2005;  62 37-45
    Google Scholar
  • 30 Wilens T E, Monuteaux M C, Snyder L E, Moore H, Whitley J, Gignac M. The clinical dilemma of using medications in substance-abusing adolescents and adults with attention-deficit/hyperactivity disorder: what does the literature tell us?.  J Child Adolesc Psychopharmacol. 2005;  15 787-798
    Google Scholar
  • 31 Petrakis I L, O'Malley S, Rounsaville B, Poling J, Hugh-Strong C, Krystal J H. Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia.  Psychopharmacology. 2004;  172 291-297
    Google Scholar
  • 32 Petrakis I L, Nich C, Ralevski E. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.  Schizophr Bull. 2006;  32 644-654
    Google Scholar
  • 33 Petrakis I L, Poling J, Levinson C, Nich C, Carroll K, Rounsaville B. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.  Biol Psychiatry. 2005;  57 1128-1137
    Google Scholar
  • 34 Miller W R, Rollnick S. Motivational Interviewing. New York: Guilford Press 1991
    Google Scholar
  • 35 Rounsaville B J. Treatment of cocaine dependence and depression.  Biol Psychiatry. 2004;  56 803-809
    Google Scholar
  • 36 Daley D C, Salloum I M, Thase M. Integrated treatment using a recovery-oriented approach. In: Westermeyer J, Weiss RD, Ziedonis DM (Hrsg). Integrated treatment for mood and substance use disorders. Baltimore: The Johns Hopkins University Press 2003: 68-89
    Google Scholar
  • 37 Ziedonis D M, Krejci J A. Dual recovery therapy: Blending psychotherapies for depression and addiction. In: Westermeyer J, Weiss RD, Ziedonis DM (Hrsg). Integrated treatment for mood and substance use disorders. Baltimore: The Johns Hopkins University Press 2003: 90-121
    Google Scholar
  • 38 Bowen R C, D'Arcy C, Keegan D, Senthilselvan A. A controlled trial of cognitive behavioral treatment of panic in alcoholic inpatients with comorbid panic disorder.  Addict Behav. 2000;  25 593-597
    Google Scholar
  • 39 Randall C L, Thomas S, Thevos A K. Concurrent alcoholism and social anxiety disorder: a first step toward developing effective treatments.  Alcohol Clin Exp Res. 2001;  25 210-220
    Google Scholar
  • 40 Avants S K, Margolin A, Kosten T R, Rounsaville B J, Schottenfeld R S. When is less treatment better? The role of social anxiety in matching methadone patients to psychosocial treatments.  J Consult Clin Psychol. 1998;  66 924-931
    Google Scholar
  • 41 Najavits L M. Seeking Safety - A treatment manual for PTSD and substance abuse. New York: Guilford Press 2002
    Google Scholar
  • 42 Najavits L M, Gallop R J, Weiss R D. Seeking safety therapy for adolescent girls with PTSD and substance use disorder: a randomized controlled trial.  J Behav Health Serv Res. 2006;  33 453-463
    Google Scholar
  • 43 Back S E, Dansky B S, Carroll K M, Foa E B, Brady K T. Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: description of procedures.  J Subst Abuse Treat. 2001;  21 35-45
    Google Scholar
  • 44 Schafer I, Najavits L M. Clinical challenges in the treatment of patients with posttraumatic stress disorder and substance abuse.  Curr Opin Psychiatry. 2007;  20 614-618
    Google Scholar
  • 45 Linehan M M, Schmidt III H, Dimeff L A, Craft J C, Kanter J, Comtois K A. Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence.  Am J Addict. 1999;  8 279-292
    Google Scholar
  • 46 Linehan M M, Dimeff L A, Reynolds S K, Welch S S, Heagerty P, Kivlahan D R. Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder.  Drug Alcohol Depend. 2002;  67 13-26
    Google Scholar
  • 47 Mayer-Bruns F, Lieb K, Dannegger E, Jacob G A. Dialektisch-behaviorale Therapie in der stationären Alkoholentwöhnung.  Nervenarzt. 2005;  76 339-343
    Google Scholar
  • 48 Ball S A. Manualized treatment for substance abusers with personality disorders: dual focus schema therapy.  Addict Behav. 1998;  23 883-891
    Google Scholar
  • 49 Ball S A, Cobb-Richardson P, Connolly A J, Bujosa C T, O'Neall T W. Substance abuse and personality disorders in homeless drop-in center clients: symptom severity and psychotherapy retention in a randomized clinical trial.  Compr Psychiatry. 2005;  46 371-379
    Google Scholar
  • 50 Ball S A. Comparing individual therapies for personality disordered opioid dependent patients.  J Personal Disord. 2007;  21 305-321
    Google Scholar
  • 51 Drake R E, Mercer-McFadden C, Mueser K T, McHugo G J, Bond G R. Review of integrated mental health and substance abuse treatment for patients with dual disorders.  Schizophr Bull. 1998;  24 589-608
    Google Scholar
  • 52 Barrowclough C, Haddock G, Tarrier N, Lewis S W, Moring J, O'Brien R, Schofield N, McGovern J. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders.  Am J Psychiatry. 2001;  158 1706-1713
    Google Scholar
  • 53 Haddock G, Barrowclough C, Tarrier N, Moring J, O'Brien R, Schofield N, Quinn J, Palmer S, Davies L, Lowens I, McGovern J, Lewis S. Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial.  Br J Psychiatry. 2003;  183 418-426
    Google Scholar
  • 54 Baker A, Bucci S, Lewin T J, Kay-Lambkin F, Constable P M, Carr V J. Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial.  Br J Psychiatry. 2006;  188 439-448
    Google Scholar
  • 55 Bellack A S, Bennett M E, Gearon J S, Brown C H, Yang Y. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.  Arch Gen Psychiatry. 2006;  63 426-432
    Google Scholar
  • 56 Hulse G K, Tait R J. Six-month outcomes associated with a brief alcohol intervention for adult in-patients with psychiatric disorders.  Drug Alcohol Rev. 2002;  21 105-112
    Google Scholar
  • 57 Swanson A J, Pantalon M V, Cohen K R. Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients.  J Nerv Ment Dis. 1999;  187 630-635
    Google Scholar
  • 58 Martino S, Carroll K M, O'Malley S S, Rounsaville B J. Motivational interviewing with psychiatrically ill substance abusing patients.  Am J Addict. 2000;  9 88-91
    Google Scholar
  • 59 Kavanagh D J, Young R, White A, Saunders J B, Wallis J, Shockley N, Jenner L, Clair A. A brief motivational intervention for substance misuse in recent-onset psychosis.  Drug Alcohol Rev. 2004;  23 151-155
    Google Scholar
  • 60 Graeber D A, Moyers T B, Griffith G, Guajardo E, Tonigan S. A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders.  Community Ment Health J. 2003;  39 189-202
    Google Scholar
  • 61 Martino S, Carroll K M, Nich C, Rounsaville B J. A randomized controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders.  Addiction. 2006;  101 1479-1492
    Google Scholar
  • 62 Santa Ana E J, Wulfert E, Nietert P J. Efficacy of group motivational interviewing (GMI) for psychiatric inpatients with chemical dependence.  J Consult Clin Psychol. 2007;  75 816-822
    Google Scholar
  • 63 D'Amelio R, Behrendt B, Wobrock T. Psychoedukation Schizophrenie und Sucht - Manual zur Leitung von Patienten- und Angehörigengruppen. München: Urban & Fischer Elsevier 2007
    Google Scholar
  • 64 Schnell T, Gouzoulis-Mayfrank E. KomPASs: Komorbidität Psychose und Abhängigkeit: Skills Training. In: Gouzoulis-Mayfrank E (Hrsg). Komorbidität Psychose und Sucht - Grundlagen und Praxis. Mit Manualen für die Psychoedukation und Verhaltenstherapie. Darmstadt: Steinkopff 2007: 105-172
    Google Scholar
  • 65 Mueser K T, Fox L. A family intervention program for dual disorders.  Community Ment Health J. 2002;  38 253-270
    Google Scholar
  • 66 Weiss R D, Najavits L M, Greenfield S F. A relapse prevention group for patients with bipolar and substance use disorders.  J Subst Abuse Treat. 1999;  16 47-54
    Google Scholar
  • 67 Weiss R D. Treating patients with bipolar disorder and substance dependence: lessons learned.  J Subst Abuse Treat. 2004;  27 307-312
    Google Scholar
  • 68 Weiss R D, Griffin M L, Kolodziej M E, Griffin M L, Kolodziej M E, Daley D C, Doreau H R, Hennen J A. A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence.  Am J Psychiatry. 2007;  164 100-107
    Google Scholar
  • 69 Aviram R B, Rhum M, Levin F R. Psychotherapy of adults with comorbid attention-deficit/hyperactivity disorder and psychoactive substance use disorder.  J Psychother Pract Res. 2001;  10 179-186
    Google Scholar
  • 70 Hesslinger B, Tebartz E L van, Nyberg E, Dykierek P, Richter H, Berner M, Ebert D. Psychotherapy of attention deficit hyperactivity disorder in adults - a pilot study using a structured skills training program.  Eur Arch Psychiatry Clin Neurosci. 2002;  252 177-184
    Google Scholar

Univ.-Prof. Dr. med. Euphrosyne Gouzoulis-Mayfrank

Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinik Köln

Kerpener Straße 62

50924 Köln

Email: e.gouzoulis@uni-koeln.de

      >